Olink Holding AB (publ)
OLK
Rank in Stocks
#4791
Olink Holding AB (publ) offers a comprehensive suite of products and services... Olink Holding AB (publ) offers a comprehensive suite of products and services tailored for life science research institutions, including academic bodies, government entities, biopharmaceutical companies, and biotechnology firms. The company's product lines include Olink Explore, which is designed to aid research in critical areas such as cardiovascular and metabolic health, oncology, neurology, and inflammation. Additionally, it features the Olink Target product line and the Olink Focus product line, the latter providing bespoke solutions for clients who have already pinpointed specific proteins or protein signatures for their studies. Beyond these, Olink supplies the Signature Q100, a dedicated platform for qPCR (quantitative Polymerase Chain Reaction) readouts. Its service portfolio encompasses Olink Analysis, offering end-to-end support from study design and expert consultation to sample preparation, assay execution, and stringent quality control of data, complemented by bioinformatics services. For data management and analysis, Olink provides the normalized protein expression (NPX) Manager, a specialized software tool enabling users to import data, validate its quality, and normalize findings in preparation for statistical analysis. Furthermore, Olink Insight serves as a cloud-based platform for visualizing and statistically analyzing NPX data. Olink Holding AB (publ) markets and sells its offerings worldwide through its proprietary direct sales force, reaching customers across the Americas, Europe, the Middle East, Africa, and the Asia Pacific region. Established in 2004 and based in Uppsala, Sweden, the company underwent a name change in January 2021 from its former identity, Knilo HoldCo AB, to its current designation. It operates as a subsidiary of Summa Equity Holding AB.
Share Price
$26.08
Last synced: 2024-07-09
Market Cap
$3.10B
Change (1 day)
0.31%
Change (1 year)
0.00%
Country
SE
Trade Olink Holding AB (publ) (OLK)
Category
Healthcare
Number of shares outstanding for Olink Holding AB (publ) (OLK)
Number of shares outstanding as of March 2024: 124.34M
According to Olink Holding AB (publ) latest financial reports and stock price the company's current number of shares outstanding is 124.34M. At the end of December 2022 the company had 119.08M shares outstanding. The number of outstanding shares is usually impacted by stock plits and shares buy back.
Shares outstanding history for Olink Holding AB (publ) (OLK) from 2019 to 2026
Shares Outstanding at the end of each year
| Year | Shares Outstanding | Change |
|---|---|---|
| 2026 (TTM) | 124.34M | 0.28% |
| 2023 | 124.00M | 4.14% |
| 2022 | 119.08M | 19.96% |
| 2021 | 99.26M | -16.59% |
| 2020 | 119.01M | 0.00% |
| 2019 | 119.01M | 0.00% |
Shares Outstanding for similar companies or competitors
| Company | Shares Outstanding | Difference | Country |
|---|---|---|---|
| 371.00M | 198.37% |
US
|
|
| 705.30M | 467.22% |
US
|
|
| 143.28M | 15.23% |
US
|
|
| - | - |
CN
|
|
| 282.00M | 126.79% |
US
|
